Effects of prebiotic consumption on serum intestinal fatty acid-binding protein levels in patients with diabetes: A case-control study.

Journal of Clinical Laboratory Analysis
Yi-Cheng HouChan-Yen Kuo

Abstract

Type 2 diabetes mellitus (T2DM) is a condition involving several molecular mechanisms related to the intestinal microbiota for its development. Intestinal fatty acid-binding protein (I-FABP) is a sensitive marker to study enterocyte damage. A prebiotic is a non-digestible food ingredient that improves host health by selectively stimulating the growth and/or activities of bacteria in the colon. We aimed to clarify the currently described effects of prebiotics in the prevention and management of T2DM. In this case-control study, we chose 68 participants with T2DM and 52 healthy participants. Both groups were further divided based on consumption of prebiotics. Forty participants with T2DM consumed prebiotics, and 28 did not; 30 healthy volunteers consumed prebiotics, and 22 did not. We used the analysis of variance to compare the inflammation levels between the case and control groups. Multiple linear regression was performed for the significantly correlated groups to estimate the influence of prebiotics on inflammation level. Age was a significant factor for difference in I-FABP levels (standardized coefficient: 0.06; P = .047). The analysis of eating habits showed that vegetarian diets produced lower I-FABP levels than non-veget...Continue Reading

References

Mar 1, 1991·The American Journal of Clinical Nutrition·T M WoleverH Eshuis
Jan 1, 1990·The American Journal of Clinical Nutrition·A O Akanji, T D Hockaday
Sep 1, 1990·JPEN. Journal of Parenteral and Enteral Nutrition·J L Rombeau, S A Kripke
Oct 31, 1989·Clinica Chimica Acta; International Journal of Clinical Chemistry·A O AkanjiT D Hockaday
May 1, 1989·The Journal of Applied Bacteriology·R Fuller
May 1, 1985·The Journal of Clinical Investigation·E W PomareJ H Cummings
Jun 1, 1995·The American Journal of Clinical Nutrition·T M WoleverP B Pencharz
Jun 1, 1995·The Journal of Nutrition·G R Gibson, M B Roberfroid
Nov 1, 1995·Critical Reviews in Food Science and Nutrition·J van LooG Smits
Aug 1, 1996·The British Journal of Nutrition·M S AllesJ B Jansen
Dec 1, 1996·The British Journal of Nutrition·N KokN Delzenne
Aug 1, 1997·The British Journal of Nutrition·A PedersenJ M Van Amelsvoort
Nov 14, 1997·The American Journal of Clinical Nutrition·M S AllesF M Nagengast
Oct 13, 1998·Alimentary Pharmacology & Therapeutics·S J Lewis, A R Freedman
Mar 18, 2000·The Journal of Nutrition·R D Rolfe
Aug 6, 2008·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Noriko YamamotoYuji Owada
Nov 20, 2013·Indian Journal of Endocrinology and Metabolism·Debmalya Sanyal
Jun 19, 2014·Nutrition Journal·Aline Corado GomesJoão Felipe Mota
Oct 4, 2015·Current Opinion in Biotechnology·Robert W HutkinsMary Ellen Sanders
Oct 18, 2016·Diabetes & Metabolism·A J CoxN P West
Feb 12, 2017·Metabolism: Clinical and Experimental·Júnia Maria Geraldo GomesRita de Cássia Gonçalves Alfenas

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Zhonghua er ke za zhi. Chinese journal of pediatrics
Journal of Pediatric Gastroenterology and Nutrition
G BoehmJ Garssen
Zhonghua er ke za zhi. Chinese journal of pediatrics
© 2021 Meta ULC. All rights reserved